PTJ
GSK icon

Paul Tudor Jones’s GSK GSK Stock Holding History

Paul Tudor Jones’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,816
Closed -$385K – 2630
2023
Q1 		$385K Buy
+10,816
New +$378K 0.01% 1769
2022
Q4 		– Sell
-23,126
Closed -$681K – 2566
2022
Q3 		$681K Buy
+23,126
New +$876K 0.01% 1178

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Paul Tudor Jones's GSK Position: Q2 2023 in Review

Paul Tudor Jones sold out of GSK (GSK) in Q2 2023, closing a stake of 10,816 shares — an estimated $385K sold.

Paul Tudor Jones first reported a position in GSK in Q3 2022 and held it in 2 quarters. The position peaked at $681K in Q3 2022. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • Paul Tudor Jones reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 10,816 GSK shares in Q2 2023, an estimated $385K.
  • Paul Tudor Jones first reported a position in GSK in Q3 2022 and held it in 2 quarters.
  • Paul Tudor Jones's GSK position peaked at $681K in Q3 2022.
  • 828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.